Δεκ272013Βιβλιογραφικά δεδομέναOff-Therapy Durability of Response to Entecavir Therapy in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Κατηγορία Βιβλιογραφικά δεδομένα27 Δεκεμβρίου 2013 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Incidence of Colorectal Cancer After Liver Transplantation for Primary Sclerosing Cholangitis: A Systematic Review and Meta-AnalysisΕπόμενοNext post:Conversions from Prograf to Advagraf in Adolescents with stable liver transplantsΣχετικά ΆρθραSpatial Organization of Neutrophil and Macrophage Populations in SurgicallyTreated Hepatocellular Carcinoma: APractical Tissue-BasedImmunophenotyping Study29 Σεπτεμβρίου 2026Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis23 Σεπτεμβρίου 2026Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort24 Αυγούστου 2026Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes23 Ιουνίου 2026Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection17 Ιουνίου 2026Physical frailty is the most important predictor of early mortality in hospitalized patients with decompensated cirrhosis15 Ιουνίου 2026
Spatial Organization of Neutrophil and Macrophage Populations in SurgicallyTreated Hepatocellular Carcinoma: APractical Tissue-BasedImmunophenotyping Study29 Σεπτεμβρίου 2026
Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis23 Σεπτεμβρίου 2026
Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort24 Αυγούστου 2026
Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes23 Ιουνίου 2026
Physical frailty is the most important predictor of early mortality in hospitalized patients with decompensated cirrhosis15 Ιουνίου 2026
